ATXI
AVENUE THERAPEUTICS, INC.
-0.02 (-3.19%)0.55USD3.3K成交股數1.8M市值4.2本益比(近四季)–股價營收比-100.0%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | 01-06 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 111K | – | – | 440K | SEC |
| 2025-03-31 | 04-02 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 33.7K | – | – | 329K | SEC |
| 2024-12-02 | 12-03 | Herskowitz Neil | Director | S 公開市場賣出 | 23 | 2.00 | 46.00 | 97 | SEC |
| 2024-11-05 | 11-07 | KRANZLER JAY D | Director | S 公開市場賣出 | 61 | 2.24 | 136.64 | 559 | SEC |
| 2024-09-30 | 10-01 | KRANZLER JAY D | Director | P 公開市場買進 | 497 | 2.50 | 1K | 620 | SEC |
| 2024-09-27 | 10-01 | KRANZLER JAY D | Director | P 公開市場買進 | 3 | 2.40 | 7.20 | 123 | SEC |
| 2024-09-23 | 09-25 | Jin David | Interim PFO and COO | A 獲配股票 | 65.0K | – | – | 65.0K | SEC |
| 2024-09-23 | 09-25 | MacLean Alexandra | Chief Executive Officer | A 獲配股票 | 170K | – | – | 170K | SEC |
| 2024-04-16 | 04-17 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 414K | – | – | 3.5M | SEC |
| 2024-01-02 | 01-03 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 2.1M | – | – | 3.1M | SEC |
| 2023-12-11 | 12-13 | Davidow Robert L | TenPercentOwner | S 公開市場賣出 | 264K | 0.14 | 37K | 681K | SEC |
| 2023-12-11 | 12-13 | Davidow Robert L | TenPercentOwner | S 公開市場賣出 | 18.0K | 0.15 | 3K | 22.0K | SEC |
| 2023-12-11 | 12-13 | Davidow Robert L | TenPercentOwner | S 公開市場賣出 | 61.0K | 0.14 | 9K | 74.0K | SEC |
| 2023-12-11 | 12-13 | Davidow Robert L | TenPercentOwner | S 公開市場賣出 | 126K | 0.14 | 18K | 216K | SEC |
| 2023-12-11 | 12-13 | Davidow Robert L | TenPercentOwner | S 公開市場賣出 | 128K | 0.14 | 18K | 147K | SEC |
| 2023-12-11 | 12-13 | Davidow Robert L | TenPercentOwner | S 公開市場賣出 | 20.0K | 0.14 | 3K | 80.0K | SEC |
| 2023-09-08 | 09-12 | Fortress Biotech, Inc. | TenPercentOwner | P 公開市場買進 | 418K | 0.72 | 301K | 1.0M | SEC |
| 2023-09-08 | 09-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 349K | 0.72 | 251K | 354K | SEC |
| 2023-03-31 | 04-04 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 52.4K | – | – | 614K | SEC |
| 2023-01-03 | 01-04 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 231K | – | – | 562K | SEC |
| 2022-12-31 | 01-04 | Fortress Biotech, Inc. | TenPercentOwner | A 獲配股票 | 90.9K | – | – | 330K | SEC |
| 2022-10-11 | 10-13 | InvaGen Pharmaceuticals, Inc. | TenPercentOwner | S 公開市場賣出 | 389K | 7.71 | 3.0M | 0 | SEC |
| 2021-12-17 | 12-21 | Oltmans Curtis Gale | Director | A 獲配股票 | 49.0K | – | – | 49.0K | SEC |
| 2021-12-17 | 12-21 | Herskowitz Neil | Director | A 獲配股票 | 49.0K | – | – | 164K | SEC |
| 2021-12-17 | 12-21 | Herskowitz Neil | Director | A 獲配股票 | 20.0K | – | – | 184K | SEC |
| 2021-12-17 | 12-21 | KRANZLER JAY D | Director | A 獲配股票 | 49.0K | – | – | 114K | SEC |
| 2021-12-17 | 12-21 | KRANZLER JAY D | Director | A 獲配股票 | 20.0K | – | – | 134K | SEC |
| 2021-12-17 | 12-20 | Vazzano Joseph Walter | Chief Financial Officer | A 獲配股票 | 101K | – | – | 166K | SEC |
| 2021-12-17 | 12-20 | Lu Lucy | President, CEO | A 獲配股票 | 412K | – | – | 749K | SEC |
| 2021-09-15 | 09-15 | Vazzano Joseph Walter | Chief Financial Officer | S 公開市場賣出 | 7.2K | 1.62 | 12K | 65.3K | SEC |
| 2021-05-06 | 05-07 | Herskowitz Neil | Director | P 公開市場買進 | 2.5K | 3.99 | 10K | 135K | SEC |
| 2020-08-20 | 08-21 | Vazzano Joseph Walter | Chief Financial Officer | S 公開市場賣出 | 3.8K | 12.13 | 47K | 57.4K | SEC |
| 2020-06-16 | 06-16 | Herskowitz Neil | Director | A 獲配股票 | 10.0K | – | – | 132K | SEC |
| 2020-06-16 | 06-16 | KRANZLER JAY D | Director | A 獲配股票 | 10.0K | – | – | 84.7K | SEC |
| 2020-03-10 | 03-10 | Vazzano Joseph Walter | Chief Financial Officer | P 公開市場買進 | 1.9K | 7.94 | 15K | 61.3K | SEC |
| 2020-03-09 | 03-10 | Vazzano Joseph Walter | Chief Financial Officer | P 公開市場買進 | 1.4K | 7.99 | 11K | 59.3K | SEC |
| 2020-03-09 | 03-10 | Vazzano Joseph Walter | Chief Financial Officer | P 公開市場買進 | 100 | 7.97 | 797.00 | 59.4K | SEC |
| 2020-02-27 | 03-02 | Herskowitz Neil | Director | P 公開市場買進 | 2.4K | 8.20 | 20K | 122K | SEC |
| 2020-02-26 | 03-02 | Herskowitz Neil | Director | P 公開市場買進 | 161 | 8.73 | 1K | 120K | SEC |
| 2020-02-25 | 02-25 | Herskowitz Neil | Director | P 公開市場買進 | 10.0K | 9.31 | 93K | 120K | SEC |
| 2020-02-25 | 02-25 | Vazzano Joseph Walter | Chief Financial Officer | P 公開市場買進 | 1.2K | 9.09 | 11K | 57.9K | SEC |
| 2019-09-12 | 09-16 | Ingram Elizabeth Garrett | Director | P 公開市場買進 | 16.0K | 6.27 | 100K | 16.0K | SEC |
| 2019-08-27 | 08-28 | Herskowitz Neil | Director | A 獲配股票 | 10.0K | – | – | 110K | SEC |
| 2019-08-27 | 08-28 | KRANZLER JAY D | Director | A 獲配股票 | 10.0K | – | – | 74.7K | SEC |
| 2019-08-09 | 08-12 | Vazzano Joseph Walter | Chief Financial Officer | S 公開市場賣出 | 2.4K | 5.56 | 13K | 56.7K | SEC |
| 2019-08-08 | 08-12 | Vazzano Joseph Walter | Chief Financial Officer | S 公開市場賣出 | 2.3K | 5.62 | 13K | 59.0K | SEC |
| 2019-06-18 | 06-19 | Herskowitz Neil | Director | P 公開市場買進 | 2.0K | 5.83 | 12K | 99.7K | SEC |
| 2019-06-17 | 06-19 | Herskowitz Neil | Director | P 公開市場買進 | 3.0K | 5.88 | 18K | 97.7K | SEC |
| 2019-04-15 | 04-15 | Herskowitz Neil | Director | P 公開市場買進 | 1.0K | 4.52 | 5K | 94.7K | SEC |
| 2019-03-29 | 03-29 | Herskowitz Neil | Director | P 公開市場買進 | 1.4K | 5.11 | 7K | 93.7K | SEC |
| 2019-03-28 | 03-29 | Herskowitz Neil | Director | P 公開市場買進 | 600 | 5.11 | 3K | 92.3K | SEC |
| 2019-02-25 | 02-25 | Herskowitz Neil | Director | P 公開市場買進 | 5.0K | 5.46 | 27K | 91.7K | SEC |
| 2019-02-05 | 02-06 | Herskowitz Neil | Director | P 公開市場買進 | 1.9K | 5.77 | 11K | 86.7K | SEC |
| 2019-02-04 | 02-06 | Herskowitz Neil | Director | P 公開市場買進 | 7.0K | 5.91 | 41K | 84.8K | SEC |
| 2019-01-30 | 02-01 | Herskowitz Neil | Director | P 公開市場買進 | 650 | 5.91 | 4K | 77.8K | SEC |
| 2019-01-29 | 01-30 | Herskowitz Neil | Director | P 公開市場買進 | 8.6K | 5.91 | 51K | 77.2K | SEC |
| 2019-01-28 | 01-30 | Herskowitz Neil | Director | P 公開市場買進 | 1.4K | 5.84 | 8K | 68.6K | SEC |
| 2018-12-10 | 12-12 | Paley Jeffrey | Director | P 公開市場買進 | 5.0K | 4.76 | 24K | 79.7K | SEC |
| 2018-12-03 | 12-12 | Paley Jeffrey | Director | P 公開市場買進 | 10.0K | 5.48 | 55K | 74.7K | SEC |
| 2018-08-07 | 08-08 | SAMAD AKHTAR | Director | G 贈與 | 14.7K | – | – | 64.7K | SEC |
| 2018-08-07 | 08-08 | Paley Jeffrey | Director | G 贈與 | 14.7K | – | – | 64.7K | SEC |
| 2018-08-07 | 08-08 | WEISS MICHAEL S | Director | G 贈與 | 14.7K | – | – | 24.7K | SEC |
| 2018-08-07 | 08-08 | Reines Scott | Interim Chief Medical Officer | G 贈與 | 10.0K | – | – | 45.0K | SEC |
| 2018-08-07 | 08-08 | KRANZLER JAY D | Director | G 贈與 | 14.7K | – | – | 64.7K | SEC |
| 2018-08-07 | 08-08 | Herskowitz Neil | Director | G 贈與 | 14.7K | – | – | 67.2K | SEC |
| 2018-08-07 | 08-08 | ROSENWALD LINDSAY A MD | Director | G 贈與 | 14.7K | – | – | 84.7K | SEC |
| 2018-08-07 | 08-08 | Lu Lucy | President, CEO | G 贈與 | 250K | – | – | 807K | SEC |
| 2018-08-07 | 08-08 | Vazzano Joseph Walter | VP Finance & Corp. Controller | G 贈與 | 30.0K | – | – | 61.4K | SEC |
| 2018-06-28 | 06-28 | Vazzano Joseph Walter | VP Finance & Corp. Controller | A 獲配股票 | 1.4K | 3.66 | 5K | 31.4K | SEC |
| 2018-06-14 | 06-15 | Lu Lucy | President, CEO | A 獲配股票 | 5.0K | 4.00 | 20K | 557K | SEC |
| 2018-06-08 | 06-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 5.2K | 4.34 | 23K | 70.0K | SEC |
| 2018-06-08 | 06-11 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 5.2K | 4.34 | 23K | 25.2K | SEC |
| 2018-06-07 | 06-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 14.8K | 4.32 | 64K | 64.8K | SEC |
| 2018-06-06 | 06-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 9.1K | 4.35 | 40K | 50.0K | SEC |
| 2018-06-05 | 06-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 8.4K | 4.28 | 36K | 40.9K | SEC |
| 2018-06-04 | 06-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 3.8K | 4.19 | 16K | 32.5K | SEC |
| 2018-06-01 | 06-12 | ROSENWALD LINDSAY A MD | Director | P 公開市場買進 | 8.7K | 4.15 | 36K | 28.7K | SEC |
| 2018-04-25 | 04-25 | Herskowitz Neil | Director | P 公開市場買進 | 1.0K | 3.80 | 4K | 52.5K | SEC |
| 2017-10-17 | 10-18 | Herskowitz Neil | Director | P 公開市場買進 | 1.0K | 5.01 | 5K | 51.5K | SEC |
| 2017-10-09 | 10-10 | Herskowitz Neil | Director | P 公開市場買進 | 500 | 5.24 | 3K | 50.5K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 ·
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 沒有 13F 資料。 | ||||
持有機構數近 12 季
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 12.9K |
|---|---|
| 與上期比 | +6.9% |
| 佔流通股數 | 0.39% |
| 日均成交量 | 13.9K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 12.9K | +6.9% | 0.39% | 13.9K | 1.0 |
| 2026-08-14 | 12.1K | +52.4% | 0.37% | 5.5K | 2.2 |
| 2026-07-31 | 7.9K | +679.9% | 0.24% | 10.2K | 1.0 |
| 2026-07-15 | 1.0K | +40.5% | 0.03% | 2.1K | 1.0 |
| 2026-06-30 | 723 | +72200.0% | 0.02% | 3.2K | 1.0 |
| 2026-06-15 | 1 | 0.0% | 0.00% | 3.0K | 1.0 |
| 2026-05-29 | 1 | 0.0% | 0.00% | 3.6K | 1.0 |
| 2026-05-15 | 1 | -100.0% | 0.00% | 9.5K | 1.0 |
| 2026-04-30 | 6.5K | +154.3% | 0.20% | 10.6K | 1.0 |
| 2026-04-15 | 2.6K | -51.6% | 0.08% | 7.7K | 1.0 |
| 2026-03-31 | 5.3K | +735.7% | 0.16% | 11.2K | 1.0 |
| 2026-03-13 | 633 | -88.0% | 0.02% | 15.1K | 1.0 |
| 2026-02-27 | 5.3K | +308.2% | 0.16% | 5.1K | 1.0 |
| 2026-02-13 | 1.3K | +128900.0% | 0.04% | 16.5K | 1.0 |
| 2026-01-30 | 1 | -95.2% | 0.00% | 17.6K | 1.0 |
| 2026-01-15 | 21 | -98.8% | 0.00% | 2.7K | 1.0 |
| 2025-12-31 | 1.8K | -78.2% | 0.05% | 6.6K | 1.0 |
| 2025-12-15 | 8.3K | -61.4% | 0.25% | 8.2K | 1.0 |
| 2025-11-28 | 21.4K | -20.2% | 0.65% | 3.8K | 5.6 |
| 2025-11-14 | 26.8K | -5.5% | 0.81% | 3.1K | 8.7 |
| 2025-10-31 | 28.4K | -21.4% | 0.86% | 3.9K | 7.3 |
| 2025-10-15 | 36.1K | -7.2% | 1.10% | 5.0K | 7.3 |
| 2025-09-30 | 39.0K | -6.8% | 1.18% | 13.7K | 2.9 |
| 2025-09-15 | 41.8K | -14.2% | 1.27% | 22.9K | 1.8 |
| 2025-08-29 | 48.7K | +0.1% | 1.48% | 8.2K | 6.0 |
| 2025-08-15 | 48.7K | -1.6% | 1.48% | 27.1K | 1.8 |